dalteparin has been researched along with 5-((4,6-dichloro-1,3,5-triazin-2-yl)amino)fluorescein in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dachary-Prigent, J; de Raucourt, E; Fischer, AM; Jozefowicz, M; Mauray, S; Talbot, JC | 1 |
1 other study(ies) available for dalteparin and 5-((4,6-dichloro-1,3,5-triazin-2-yl)amino)fluorescein
Article | Year |
---|---|
Mechanism of factor IXa inhibition by antithrombin in the presence of unfractionated and low molecular weight heparins and fucoidan.
Topics: Anticoagulants; Antithrombins; Dalteparin; Enoxaparin; Enzyme Inhibitors; Factor IXa; Fluoresceins; Fluorescence Polarization; Fluorescent Dyes; Heparin; Humans; Kinetics; Nadroparin; Polysaccharides; Protein Binding | 1998 |